Erlotinib vs Finasteride

Erlotinib vs Finasteride: Overview

This comparison examines the pharmacological differences between Erlotinib and Finasteride.

Mechanism of Action

Erlotinib: Reversible inhibitor of EGFR (HER1) tyrosine kinase, blocking autophosphorylation.

Finasteride: Competitive inhibitor of 5-alpha-reductase type II.

Pharmacokinetics

Half-life: Erlotinib — 36 hours; Finasteride — 5-6 hours.

Chemical Properties

Molecular Formula: Erlotinib — C22H23N3O4; Finasteride — C23H36N2O2.

Molecular Weight: Erlotinib — 393.4380 g/mol; Finasteride — 372.5490 g/mol.

Type: Erlotinib — Small molecule; Finasteride — Small molecule.